Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in resected high-risk colon cancer patients – study protocol for the PIPAC-OPC3 Trial. A prospective, controlled phase 2 Study

BACKGROUND: Peritoneal metastasis (PM) is the second most common site of recurrence in colon cancer (CC) patients and accounts for approximately one-third of all recurrences. Patients with T4 or intraperitoneal perforated colon cancers have an increased risk of developing PM, and since manifest PM i...

Descripción completa

Detalles Bibliográficos
Autores principales: Graversen, Martin, Detlefsen, Sönke, Fristrup, Claus, Pfeiffer, Per, Mortensen, Michael Bau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404996/
https://www.ncbi.nlm.nih.gov/pubmed/30911655
http://dx.doi.org/10.1515/pp-2018-0107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404996/
https://www.ncbi.nlm.nih.gov/pubmed/30911655
http://dx.doi.org/10.1515/pp-2018-0107

Ejemplares similares